S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden replacement revealed? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden replacement revealed? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden replacement revealed? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden replacement revealed? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
ASX:PAA

PharmAust (PAA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free PAA Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.27 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.88%
Price Target
N/A
Stock Analysis
Stock Analysis
PAA stock logo

About PharmAust Stock (ASX:PAA)

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.

PAA Stock News Headlines

April 10, 2024 | msn.com
PharmAust inks approval from Macquarie University for Open-Label MND extension study
March 27, 2024 | finance.yahoo.com
We Think PharmAust (ASX:PAA) Can Afford To Drive Business Growth
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 14, 2024 | msn.com
Closing Bell: ASX a little lower after hosting a Big 4 bank midweek spank
March 14, 2024 | msn.com
PharmAust files groundbreaking MND/ALS clinical data with the FDA
March 13, 2024 | fool.com.au
If you'd put $30,000 in this ASX biotech stock 4 months ago, you'd have $140,000 now
February 28, 2024 | finance.yahoo.com
PharmAust advances monepantel for motor neurone disease towards FDA approval
February 28, 2024 | finanznachrichten.de
PharmAust Limited: PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 28, 2024 | msn.com
PharmAust’s MPL could offer MND/ALS sufferers up to 56.5 months additional life expectancy
February 28, 2024 | finance.yahoo.com
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
February 21, 2024 | msn.com
PharmAust forms scientific advisory board to guide next phase of monepantel for treatment of MND/ALS
February 16, 2024 | msn.com
FDA shows the way for accelerated approval of PharmAust’s monepantel in MND
February 14, 2024 | finance.yahoo.com
PharmAust (ASX:PAA) delivers shareholders incredible 42% CAGR over 5 years, surging 11% in the last week alone
February 14, 2024 | msn.com
PharmAust extension study begins as analysis shows MND/ALS drug ‘defied the odds’
February 10, 2024 | morningstar.com
Plains All American Pipeline LP PAA
February 1, 2024 | markets.businessinsider.com
Plains All American Pipeline L.P.
January 30, 2024 | benzinga.com
Plains All American Stock (NASDAQ:PAA) Dividends: History, Yield and Dates
January 30, 2024 | msn.com
PharmAust gets ethics committee green light for open-label MND extension study
January 28, 2024 | msn.com
FDA offers PharmAust clear guidance for orphan drug designation approval
January 23, 2024 | morningstar.com
Plains All American Pipeline LP
January 16, 2024 | msn.com
PharmAust partners with US-based Berry Consultants for Phase 2/3 study
January 1, 2024 | msn.com
PharmAust just got a pre-IND meeting with the US FDA to kick off ‘24
December 21, 2023 | msn.com
Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust
December 20, 2023 | msn.com
Santa (and ATO) delivers PharmAust $550k cash boost for Christmas
December 12, 2023 | msn.com
Prominent Perth fundie the main backer in PharmAust’s $3.5m cap raise
December 2, 2023 | au.finance.yahoo.com
PharmAust Limited (ECQ.F)
See More Headlines
Receive PAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmAust and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:PAA
CUSIP
N/A
CIK
N/A
Web
www.pharmaust.com
Phone
61 8 6161 7412
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,750,000.00
Net Margins
-177.28%
Pretax Margin
N/A
Return on Equity
-101.98%
Return on Assets
-31.99%

Debt

Debt-to-Equity Ratio
26.97
Current Ratio
4.55
Quick Ratio
2.24

Sales & Book Value

Annual Sales
$3.71 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
10.50
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
394,330,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.27
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Sam Michael Wright A.C.I.S. (Age 46)
    ACIS, AFin, DipAcc, M.A.I.C.D., MAICD, Finance Director, Company Secretary & Non-Executive Director
    Comp: $138k
  • Ms. Fiona Milner
    General Manager of Epichem Pty Ltd
  • Dr. Michael Thurn Ph.D.
    CEO & Director
  • Dr. Gary Pitt
    Head of Chemistry
  • Dr. James Rixson
    Head of Production

Key Competitors

View All Competitors

Insiders


This page (ASX:PAA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing